Shire plc News Headlines

SHPG 
$244.86
*  
1.69
0.69%
Get SHPG Alerts
*Delayed - data as of Aug. 28, 2014  -  Find a broker to begin trading SHPG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pre-Market Most Active for Jul 8, 2014 : GRPN, AAPL, CAMT, ALU, SDRL, GTAT, SHPG, MT, NOK, GPRO, DAL, BAC
7/8/2014 8:39:55 AM - NASDAQ.com News

Markets off to a sluggish Tuesday morning
7/8/2014 8:33:00 AM - Market Intelligence Center

AbbVie Offers $51 Billion for Shire
7/8/2014 8:25:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a revised -2-
7/8/2014 8:05:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a revised possible offer
7/8/2014 8:05:00 AM - Dow Jones Business News

AbbVie Increases Bid For Shire To Indicative Value Of £51.15/Shr - Quick Facts
7/8/2014 8:04:00 AM - RTT News

Roche's Alectinib Approved in Japan - Analyst Blog
7/7/2014 11:40:00 AM - Zacks.com

RedHill Acquires Mesupron from Wilex - Analyst Blog
7/3/2014 1:50:00 PM - Zacks.com

AbbVie: Barclays Is Late To Upgrade, Using Highly Favorable Assumptions
7/3/2014 11:38:00 AM - Seeking Alpha

What Stocks Top Funds Are Buying Now
7/2/2014 7:09:00 PM - Investor's Business Daily

Roche Acquires Seragon Pharma - Analyst Blog
7/2/2014 12:10:00 PM - Zacks.com

Amicus Up on Migalastat Study Update - Analyst Blog
7/1/2014 4:45:00 PM - Zacks.com

Roche Launches cobas 6500 Testing System - Analyst Blog
7/1/2014 12:00:00 PM - Zacks.com

AmerisourceBergen Acquires Minority Stake In Profarma - Analyst Blog
6/30/2014 6:00:00 PM - Zacks.com

Roche's Avastin Receives Positive Opinion from CHMP - Analyst Blog
6/30/2014 5:05:00 PM - Zacks.com

AbbVie's Oncology Candidate Progresses - Analyst Blog
6/30/2014 4:45:00 PM - Zacks.com

Consider Shire Pharmaceuticals Now; 20%+ Upside Left In Takeover Bid By AbbVie
6/30/2014 10:38:00 AM - Seeking Alpha

Shire Gets $248 Mln Refund From Canada; Expects Further $162 Mln In Late 2014
6/30/2014 3:31:00 AM - RTT News

Shire Snubs AbbVie Offer Again, Favorable Ruling for Vyvanse - Analyst Blog
6/26/2014 2:25:00 PM - Zacks.com

LONDON MARKETS: U.K. Stocks Fall As Part Of Global Equity Slump
6/25/2014 12:26:00 PM - Dow Jones Business News

Shire Leads Gains Among European ADRs After Abbvie Statement on Possible Takeover, U.S. Patent Ruling
6/25/2014 12:20:59 PM - MT Newswires

LONDON MARKETS: U.K. Stocks Pull Lower As Part Of Global Equity Slump
6/25/2014 9:10:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer -4-
6/25/2014 7:15:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer -3-
6/25/2014 7:15:00 AM - Dow Jones Business News

AbbVie Inc. Statement regarding a possible offer -2-
6/25/2014 7:15:00 AM - Dow Jones Business News